Progressive Supranuclear Palsy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104
Condition: Progressive Supranuclear Palsy (PSP) Intervention: Drug: ABBV-8E12 Sponsor: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2018 Category: Research Source Type: clinical trials